Skip to main content

Table 1 Demographic and clinical characteristics

From: White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease

Characteristics

FTLD-TDP

(n = 22)

FTLD-tau (Pick's)

(n = 10)

FTLD-tau (CBD)

(n = 11)

FTLD-tau (PSP)

(n = 15)

AD

(n = 15)

HC

(n = 35)

P-values

Age at baseline

66.5 (8.7)

67.4 (9.6)

67.4 (6.6)

71.4 (5.3)

69.1 (10.0)

71.2 (7.8)

0.278

Age at onset of symptoms

63.2 (8.5)

63.5 (11.1)

63.9 (6.0)

68.3 (5.8)

65.6 (10.5)

..

0.454

Disease duration at baseline assessment (years)

3.9 (3.7)

3.9 (3.7)

3.6 (1.7)

3.1 (1.7)

3.6 (2.2)

..

0.903

Age at imaging

68.2 (7.6)

67.8 (9.8)

68.1 (6.2)

72.0 (5.0)

69.5 (10.5)

71.6 (7.5)

0.059

Age at death

73.1 (10.5)

74.9 (8.0)

71.1 (5.9)

76.4 (5.3)

74.5 (10.5)

..

0.612

Female

10 (45%)

4 (40%)

8 (73%)

6 (40%)

5 (33%)

14 (40%)

0.455

Handedness (R/L/A)

17/4/1

7/2/1

10/1/0

13/1/1

15/0/0

16/0/1

0.512

Education (years)

15.0 (3.2)

15.4 (4.1)

13.5 (3.2)

15.3 (3.2)

16.0 (5.5)

14.4 (3.3)

0.570

MMSE (/30)

22.7 (6.3)

16.9 (10.6)

21.9 (5.8)

24.1 (6.2)

19.9 (6.4)

28.9 (0.9)

<0.0001*

DRS (/144)

108.0 (21.1)

102.6 (36.9)

103.4 (25.2)

115.4 (18.9)

110.9 (21.2)

140.5 (2.6)

<0.0001*

Total NPI (/144)

25.1 (10.9)

42.2 (23.7)

18.3 (18.6)

14.7 (15.1)

11.9 (8.0)

..

<0.0001*

Vascular risk factors

 Hypertension

6 (27%)

2 (20%)

3 (27%)

5 (33%)

4 (27%)

9 (26%)

0.972

 Hyperlipidemia

5 (23%)

0 (0%)

3 (27%)

2 (13%)

6 (40%)

1 (3%)

0.168

 Diabetes mellitus

0 (0%)

1 (10%)

2 (18%)

0 (0%)

0 (0%)

0 (0%)

0.177

 History of stroke/TIA

2 (10%)

1 (10%)

0 (0%)

0 (0%)

1 (6.6%)

0 (0%)

0.705

Total WMH (mm3)

8032 (8889)

3088 (3238)

4179 (4664)

4695 (4872)

4840 (5045)

3053 (11947)

0.058

  1. Data are n (%) and mean (± standard deviation). All percentages were rounded to the nearest whole number
  2. Brain imaging acquisition was performed within 12 weeks of participant’s baseline assessment
  3. *Significant difference between groups (P < 0.05) on ANOVA with post hoc Bonferroni tests for continuous variables, χ2/Fisher Exact Tests for categorical/dichotomous variables, respectively, and Kruskal-Wallis with post hoc Mann-Whitney U tests for non-normally distributed data
  4. Abbreviations: AD Alzheimer’s disease, CBD corticobasal degeneration, DRS Dementia Rating Scale, FTLD frontotemporal lobar degeneration, HC healthy controls, MMSE Mini-Mental State Examination, NPI Neuropsychiatric Inventory, PSP progressive supranuclear palsy, TIA transient ischemic attack, WMH white matter hyperintensity